[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Page 15525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06567]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2015-0112]
2016 Guideline for Prescribing Opioids for Chronic Pain
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
availability of the 2016 Guideline for Prescribing Opioids for Chronic
Pain. CDC published the Guideline in the March 18, 2016 edition of
CDC's Morbidity and Mortality Weekly Report, Recommendations and
Reports. This notice provides the public with official notice of the
availability of the Guideline.
DATES: CDC published the Guideline on March 18, 2016 in the Morbidity
and Mortality Weekly Report, Recommendations and Reports.
FOR FURTHER INFORMATION CONTACT: Arlene I. Greenspan, National Center
for Injury Prevention and Control, Centers for Disease Control and
Prevention, 4770 Buford Highway NE., Mailstop F-63, Atlanta, Georgia
30341. Telephone: (770) 488-4694; email: [email protected].
SUPPLEMENTARY INFORMATION: On December 14, 2015, CDC published a notice
in the Federal Register announcing the opening of a docket for public
comment on the draft 2016 Guideline for Prescribing Opioids for Chronic
Pain (81 FR 77351). CDC also had a public comment opportunity during
the National Center for Injury Prevention and Control's Board of
Scientific Counselors meeting on January 28, 2016.
CDC developed the Guideline to provide recommendations about opioid
prescribing for primary care providers who are treating adult patients
with chronic pain in outpatient settings, outside of active cancer
treatment, palliative care, and end-of-life care. The Guideline
summarizes scientific knowledge about the effectiveness and risks of
long-term opioid therapy and provides recommendations for when to
initiate or continue opioids for chronic pain; opioid selection,
dosage, duration, follow-up, and discontinuation; and assessing risk
and addressing harms of opioid use.
CDC received more than 4,350 public comments on the draft Guideline
from professional organizations, industry, academia, and the public.
All comments were carefully reviewed and considered in the development
of the final Guideline.
The ``CDC Guideline for Prescribing Opioids for Chronic Pain--
United States, 2016'' has been added to the docket and can also be
found at www.cdc.gov/MMWR.
Dated: March 17, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2016-06567 Filed 3-22-16; 8:45 am]
BILLING CODE 4163-18-P